Last updated: June 2026 · Reviewed June 2026 · Built by the InjectBuddy team
Where should you inject testosterone (TRT)? IM and SubQ sites compared
The four most common Testosterone (TRT) injection sites are the ventrogluteal hip and vastus lateralis (outer thigh) for intramuscular oil, the deltoid (shoulder) for smaller volumes, and the abdominal fat for subcutaneous testosterone. The right choice depends on whether your prescription is IM or SubQ, how much you can reach to inject yourself, and how big the draw volume is. This guide walks through each site, compares needle length and volume limits, works through dose examples, and answers the questions people ask most.
Key takeaways:
- The ventrogluteal site is the most evidence-backed IM spot — thin fat cover, away from the sciatic nerve.
- IM testosterone uses a longer 1 to 1.5 inch needle; SubQ uses a short 0.5 inch or insulin needle into pinched fat.
- Comfort caps roughly: ventrogluteal/thigh ~2 mL, deltoid ~1 mL, SubQ ~0.5 to 1 mL per spot.
- Work out your exact draw with the Testosterone (TRT) dose calculator before you pick a site and needle.
IM vs SubQ decides the site first
Before comparing spots on the body, settle the route. Injectable testosterone esters such as cypionate and enanthate are oil-based, and the FDA label for testosterone cypionate states the drug is "for intramuscular use only" and that injections "should be given deep in the gluteal muscle" (DailyMed). That is the traditional route. In practice many prescribers now also direct subcutaneous testosterone, where the same oil is deposited into the fat layer instead of muscle — studies find SubQ reaches comparable blood levels at the same weekly dose with a shorter needle.
The route changes three things at once: which sites are usable, the needle length, and the comfortable volume per spot. A SubQ injection needs a pinch of fat and a short needle; an IM injection needs a muscle belly and a needle long enough to clear the fat above it. Your prescriber sets the route — this page converts the prescribed dose into a draw and matches it to a site, it does not decide treatment.
The four common Testosterone (TRT) sites compared
This is the core reference: each common Testosterone (TRT) site, whether it is IM or SubQ, the usual needle length, and a rough comfort cap on volume per injection. Needle length scales with body fat — leaner users at the lower end, larger adults at the higher end.
| Site | Route | Needle length | Typical max volume |
|---|---|---|---|
| Ventrogluteal (hip) | IM | 1–1.5 in (25–38 mm) | ~2 mL |
| Vastus lateralis (thigh) | IM | 1–1.5 in (25–38 mm) | ~2 mL |
| Deltoid (shoulder) | IM | 1 in (25 mm) | ~1 mL |
| Abdomen (love handle) | SubQ | 0.5 in / insulin (8–13 mm) | ~0.5–1 mL |
Needle gauge is separate from length: a thicker 18–21G needle draws thick oil from the vial, then many users swap to a thinner 23–25G needle of the right length to inject. See needle sizes explained for the gauge-to-use mapping.
Ventrogluteal (hip) — the evidence-backed IM site
The ventrogluteal site sits on the side of the hip, located by placing your palm on the bony point of the hip and spreading the index and middle fingers into a V toward the hip bone. A review in Patient Preference and Adherence (2018) concluded it is "the safest injection site" because it has thinner subcutaneous tissue, well-developed muscle, and fewer nerves and vessels than the older dorsogluteal (buttock) site — it avoids the sciatic nerve and superior gluteal artery.
Vastus lateralis (outer thigh) — easiest to self-inject
The outer thigh, in the band between hip and knee, is the simplest site to see and reach for self-injection, which is why many people on Testosterone (TRT) use it. It is a large muscle that tolerates up to about 2 mL.
Deltoid (shoulder) — small volumes only
The deltoid takes a 1 inch needle and is fine for small IM volumes (about 1 mL), useful when you split a dose. It is a smaller muscle, so it is not the place for a 2 mL draw.
Abdomen (SubQ) — the subcutaneous option
For SubQ testosterone, the soft fat of the lower abdomen (a couple of inches from the navel) or the upper outer thigh is pinched and injected with a short needle. Keep individual SubQ volumes small to limit a fluid lump under the skin.
How this is calculated (dose to draw to site)
Choosing a site is the last step; the volume comes first. The arithmetic is always the same: volume (mL) = dose (mg) ÷ concentration (mg/mL). On a U-100 insulin syringe, multiply mL by 100 to read units. Once you know the volume, the table above tells you which sites can comfortably hold it.
120 mg/week, split twice weekly = 60 mg per shot. Vial 200 mg/mL. 60 ÷ 200 = 0.30 mL = 30 units. At 0.30 mL, any site works — thigh, ventrogluteal, or deltoid.
200 mg once weekly on a 200 mg/mL vial. 200 ÷ 200 = 1.0 mL = 100 units. 1 mL fits the deltoid, but the ventrogluteal or thigh are more comfortable for a full mL.
250 mg weekly on 200 mg/mL = 1.25 mL. That exceeds the ~1 mL deltoid comfort cap, so use a large IM site or split it across two spots.
A 2.0 mL draw split into two = 1.0 mL per site. Inject left and right ventrogluteal on the same day to halve the volume and the soreness.
140 mg/week split into two SubQ shots = 70 mg each on a 200 mg/mL vial: 70 ÷ 200 = 0.35 mL = 35 units. Comfortably under the ~0.5–1 mL SubQ cap.
100 mg on a 250 mg/mL vial: 100 ÷ 250 = 0.40 mL. The same 100 mg on 200 mg/mL is 0.50 mL — a richer vial means a smaller injection at every site.
105 mg/week as every-other-day microdoses = 30 mg per shot on 200 mg/mL: 30 ÷ 200 = 0.15 mL = 15 units. Tiny volumes like this suit SubQ or a small IM site with frequent rotation.
Site rotation diagram
Rotation matters because injecting the same spot repeatedly can build scar tissue and make absorption uneven. Keeping a simple left/right schedule across these sites — see rotating injection sites — spreads the load. Sticking to clean technique on every injection is non-negotiable: the CDC stresses a new sterile needle and syringe for each injection and aseptic skin prep, and the WHO best-practices toolkit sets the same standard for safe injection.
Common site-selection mistakes
The most frequent error is using an IM needle that is too short for the chosen site, so oil meant for muscle lands in fat and absorbs unpredictably — larger adults often need the full 1.5 inch at the ventrogluteal and thigh. The opposite mistake is forcing a large volume into a small site: a 2 mL draw in the deltoid is asking for soreness when the thigh or hip would take it easily.
A third mistake is using the old dorsogluteal (buttock) target instead of the ventrogluteal hip; the dorsogluteal site sits near the sciatic nerve and superior gluteal artery, which is exactly why the evidence favours the ventrogluteal landmark. Finally, never copy someone else's "units" without matching the vial concentration — 30 units from a 200 mg/mL vial is a different dose than 30 units from 250 mg/mL.
So, where should you inject testosterone (TRT)?
For intramuscular testosterone the ventrogluteal hip is the most evidence-backed site, with thin fat cover and a safe distance from the sciatic nerve; the vastus lateralis (outer thigh) is the easiest to self-inject. For subcutaneous testosterone the lower abdomen or upper outer thigh fat is used with a short needle. Match your site to your draw volume — large IM sites take up to ~2 mL, the deltoid ~1 mL, and SubQ spots ~0.5–1 mL — then confirm the exact volume with the Testosterone (TRT) dose calculator before you draw up.
FAQs
Where should you inject testosterone (TRT)?
Is subcutaneous testosterone as good as intramuscular?
What needle length do I use for each Testosterone (TRT) site?
How much testosterone can I inject in one site?
How do I know which site is right for my draw volume?
Sources
- Kara D, et al. Creating a change in the use of ventrogluteal site for intramuscular injection. Patient Preference and Adherence 2018. ventrogluteal as the safest IM site (PMC6145361).
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018. Endocrine Society testosterone therapy guideline (PMID 29562364).
- DailyMed (FDA). Testosterone Cypionate Injection label — intramuscular, deep gluteal administration. DailyMed testosterone cypionate label.
- CDC. Safe Injection Practices to Prevent Transmission of Infections to Patients. CDC injection safety guidance.
- WHO. Best practices for injections and related procedures toolkit. WHO injection safety toolkit.
- Kishi T, et al. Intramuscular Injection. StatPearls, NCBI Bookshelf. StatPearls intramuscular injection technique and sites.
- Roldán-Chicano MT, et al. Adverse effects of dorsogluteal versus ventrogluteal intramuscular injection: a systematic review and meta-analysis. Nursing Open 2023. dorsogluteal vs ventrogluteal adverse-effect meta-analysis (PMC10415997).
- Palma S, Strohfus P. Body Mass Index: A Reliable Predictor of Subcutaneous Fat Thickness and Needle Length for Ventral Gluteal Intramuscular Injections. Am J Ther 2019. BMI, fat thickness and needle length for ventrogluteal injection (PMID 27574934).
- Figueiredo MG, Gagliano-Jucá T, Basaria S. Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option. J Clin Endocrinol Metab 2021. subcutaneous testosterone as a safe, practical route (PMC9006970).
- Spratt DI, et al. Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection: a pilot study. Am J Health-Syst Pharm 2018. subcutaneous vs intramuscular testosterone pharmacokinetics (PMID 29367424).
- Kovac JR, et al. Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate. J Urol 2022. IM cypionate vs SubQ enanthate outcomes in hypogonadal men (PMID 34694927).
This guide is for general educational purposes only and does not constitute medical advice. Testosterone route, dose, and injection site must be set by your prescriber. Always follow your prescriber's specific instructions and use clean technique.